STUART LEWTAN – BOARD MEMBER
Stuart Lewtan is the founder & CEO of Zintro, Inc. (www.zintro.com). Zintro is a next-generation talent acquisition platform that helps companies source highly specialized job candidates, consultants and experts. Zintro’s 100,000 experts span over 10,000 highly specialized areas of expertise across all industry sectors, geographies and job functions.
Prior to founding Zintro, Mr. Lewtan was Founder, Chairman & CEO of Lewtan Technologies, a 100+ person company providing information & software to the asset-backed securities industry. Mr. Lewtan was a participant in the American Securitization Forum’s (ASF’s) SEC’s Regulation AB Committee and has authored several articles and spoken at and chaired numerous industry events. In December of 2004, Lewtan Technologies was sold to DMG Information, a subsidiary of UK based DMGT. In 2014, Lewtan Technologies was sold to Moody’s.
Mr. Lewtan is a former Trustee at Brandeis University (Chairman of the Audit Committee) as well as former Overseer for the International Business School at Brandeis. Mr. Lewtan is an Overseer at Brigham & Women’s Hospital and also a member of the Gastrointestinal Cancer Center Committee of the Dana Farber Cancer Institute. Stuart was a member of CommonAngels, a prominent angel investment group targeting early stage companies.
- Brandies, BS
- Indiana University, BS